DalsnaFinance

Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software

Markets PR Newswire By PR Newswire 14 Jul 2026 12:38 1 min read
Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software

Automated software helps respiratory therapists identify ineffective efforts, the most frequent type of patient-ventilator asynchrony in mechanically ventilated patients SANTA CLARA, Calif., July 14, 2026 /PRNewswire/ -- Autonomous Healthcare today announced that the U.S. Food and Drug...

Automated software helps respiratory therapists identify ineffective efforts, the most frequent type of patient-ventilator asynchrony in mechanically ventilated patients SANTA CLARA, Calif., July 14, 2026 /PRNewswire/ -- Autonomous Healthcare today announced that the U.S. Food and Drug...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.